Patent Assignment
Reel/Frame 040745/0950
Security Interest
Recorded: 2016-12-22
Pages: 9
Assignor
MEDICURE INTERNATIONAL INC.
Executed: 2016-11-17
Assignee
CROWN CAPITAL FUND IV MANAGEMENT INC.
SUITE 4330, 77 KING STREET W., P.O. BOX 196, TORONTO, M5K 1H6, CANADA
Covered Properties
(10)
Compositions for Inhibiting Platelet Aggregation
Patent:
5,733,919 →
Application:
08/735,878 →
Novel Sulfonamide Fibrinogen Receptor Antagonists
Patent:
5,814,643 →
Application:
08/861,545 →
Angioplasty Procedure Using Nonionic Contrast Media
Patent:
5,978,698 →
Application:
08/943,872 →
Compositions for Inhibiting Platelet Aggregation
Patent:
5,972,967 →
Application:
08/965,922 →
Compositions for Inhibiting Platelet Aggregation
Patent:
5,965,581 →
Application:
09/079,776 →
Novel Sulfonamide Fibrinogen Receptor Antagonists
Patent:
5,880,136 →
Application:
09/130,334 →
Novel Sulfonamide Fibrinogen Receptor Antagonists
Patent:
6,040,317 →
Application:
09/221,044 →
Platelet Aggregation Inhibition Using Low Molecular Weight Heparin in Combination with a Gp Iib/Iiia Antagonist
Patent:
6,136,794 →
Application:
09/240,429 →
Method for Inhibiting Platelet Aggregation
Method for Inhibiting Platelet Aggregation
Application:
14/991,326 →
Publication:
US 2016/0120856
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.